Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
BOOST logo

The Better Outcomes for Older people with Spinal Trouble (BOOST) trial has opened its first pilot site for recruitment. The Royal Orthopaedic Hospital in Birmingham is now recruiting patients for the trial which is studying different physiotherapy treatments for people who suffer back and leg pain due to lumbar spinal stenosis. The trial will be gradually rolled out across at least 10 hospitals in England over the next 6 months.

 

Participants who are aged 65 and over, registered with a Primary Care practice and report symptoms consistent with neurogenic claudication may be eligible to join the trial as a participant. The trial’s primary outcome is to evaluate the clinical and cost-effectiveness of a physiotherapy rehabilitation programme for people with lower back and leg pain compared to usual care.

 

The BOOST trial is part of a wider programme of research looking at pain and physical activity in older people.

 

For more information please visit www.boosttrial.org.uk

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.